Quarter Ending:
Sequent Scientific
BSE: 512529|ISIN: INE807F01019|SECTOR: Pharmaceuticals
LIVE
BSE
May 23, 15:12
138.00
-4 (-2.82%)VOLUME 503
Sequent Scientific is not listed on NSE
| category of Shareholder |
No. of Share-holders |
Total NO. of Shares |
Total No. of Shares held in Dematerialized Form |
Total Shareholding as a % of total No. of Shares As a % of
(A+B) As a % of
(A+B+C) |
Shares pledged or otherwise encumbered Number of
shares As a % of Total
No. of Shares |
| (A) Shareholding of Promoter and Promoter Group | |||||||
|---|---|---|---|---|---|---|---|
| (1) Indian | |||||||
| Individuals / Hindu Undivided Family | 3 | 11,189,979 | 11,189,979 | 47.34 | 47.34 | ||
| Bodies Corporate | 4 | 2,944,532 | 2,244,532 | 12.46 | 12.46 | 1,000,000 | 33.96 |
| Sub Total | 7 | 14,134,511 | 13,434,511 | 59.80 | 59.80 | 1,000,000 | 7.07 |
| (2) Foreign | |||||||
| Total shareholding of Promoter and Promoter Group (A) | 7 | 14,134,511 | 13,434,511 | 59.80 | 59.80 | 1,000,000 | 7.07 |
| (B) Public Shareholding | |||||||
| (1) Institutions | |||||||
| Foreign Institutional Investors | 1 | 41,000 | 41,000 | 0.17 | 0.17 | ||
| Sub Total | 1 | 41,000 | 41,000 | 0.17 | 0.17 | ||
| (2) Non-Institutions | |||||||
| Bodies Corporate | 182 | 961,117 | 961,117 | 4.07 | 4.07 | ||
| Individuals | |||||||
| Individual shareholders holding nominal share capital up to Rs. 1 lakh | 2,198 | 898,705 | 888,450 | 3.80 | 3.80 | ||
| Individual shareholders holding nominal share capital in excess of Rs. 1 lakh | 20 | 1,752,806 | 1,752,806 | 7.42 | 7.42 | ||
| Any Others (Specify) | 76 | 5,847,052 | 5,147,052 | 24.74 | 24.74 | ||
| Non Resident Indians | 46 | 1,921,362 | 1,921,362 | 8.13 | 8.13 | ||
| Clearing Members | 26 | 18,421 | 18,421 | 0.08 | 0.08 | ||
| Directors & their Relatives & Friends | 1 | 23,348 | 23,348 | 0.10 | 0.10 | ||
| Trusts | 2 | 700,050 | 50 | 2.96 | 2.96 | ||
| Foreign Corporate Bodies | 1 | 3,183,871 | 3,183,871 | 13.47 | 13.47 | ||
| Sub Total | 2,476 | 9,459,680 | 8,749,425 | 40.02 | 40.02 | ||
| Total Public shareholding (B) | 2,477 | 9,500,680 | 8,790,425 | 40.20 | 40.20 | ||
| Total (A)+(B) | 2,484 | 23,635,191 | 22,224,936 | 100.00 | 100.00 | 1,000,000 | 4.23 |
| (C) Shares held by Custodians and against which Depository Receipts have been issued-m | |||||||
| (1) Promoter and Promoter Group | |||||||
| (2) Public | |||||||
| Sub Total | |||||||
| Total (A)+(B)+(C) | 2,484 | 23,635,191 | 22,224,936 | 100.00 | 1,000,000 | 4.23 | |
>> Click here for Shareholding belonging to the category "Promoter and Promoter Group"
>> Click here for Shareholding belonging to the category "Public" and holding more than 1% of the Total No. of Shares
Quick Links for Sequent Scientific
Related Searches
Sequent Scientific Stock Price, Sequent Scienti Stock Quote, Sequent Scienti Results , Sequent Scienti News ..
More »
Follow moneycontrol.com
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News |
Markets |
IPO |
Technicals |
Mutual Fund |
Commodities |
Best Portfolio Manager |
Bse Sensex |
Bombay Stock Exchange |
Share Market Live |
Recession 2011 |
Commodities Price |
Silver Price/Rate in India |
Gold Price/Rate in India |
Crude Oil |
USD to INR |
National Stock Exchange |
Bank Fixed Deposits |
Company Fixed Deposits |
Small Savings Schemes |
Property rates in India |
Rss Feeds | Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | BSE A Group Companies | BSE B Group Stocks | Union Budget
| Financial Glossary
|
Message Board |
Moneybhai |
India's Premiere Technology Guide |
History India | Davos
| Zee Entertainment Enterprises | BSE SENSEX | Wockhardt | Ranbaxy Laboratories Limited (ADR) | Vedanta Resources | Airports | Indian rupee | Network 18 | Indian Bank | State Bank of India (GDR)
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Statement | Terms of Use | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.